These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4818768)

  • 21. Effect of ergocornine on prolactin secretion by hypophysial homografts.
    Malven PV; Hoge WR
    Endocrinology; 1971 Feb; 88(2):445-9. PubMed ID: 5540057
    [No Abstract]   [Full Text] [Related]  

  • 22. [The mode of action of ergocornin on the secretion of prolactin].
    Pasteels JL; Ectors F
    Arch Int Pharmacodyn Ther; 1970 Jul; 186(1):195-6. PubMed ID: 5473176
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition by 2-Br alpha-ergocryptine-mesilate (CB-154) of suckling-induced pituitary prolactin depletion in lactating rats.
    Flückiger E; Kovacs E
    Experientia; 1974 Oct; 30(10):1173. PubMed ID: 4435126
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of perphenazine and ergocornine on growth reactions of the adenohypophysis.
    Schreiber V; Rohácová J
    Acta Univ Carol Med (Praha); 1973; 19(3-4):271-82. PubMed ID: 4804221
    [No Abstract]   [Full Text] [Related]  

  • 25. Control of prolactin secretion by the hypothalamic catecholamines.
    MacLeod RM; Login I
    Adv Sex Horm Res; 1976; 2():211-31. PubMed ID: 13627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of clozapine on dopamine-induced inhibition of prolactin release from cultured rat pituitary cells.
    Braghiroli L; Ponzianelli A; Fiani M; De Feo G; Cheng CY; Mazzanti G
    Pharmacol Res; 1997 Mar; 35(3):173-5. PubMed ID: 9229404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of mammary tumorigenesis by ergot alkaloids and promotion of mammary tumorigenesis by pituitary isografts in adreno-ovariectomized mice.
    Yanai R; Nagasawa H
    J Natl Cancer Inst; 1972 Mar; 48(3):715-9. PubMed ID: 5058970
    [No Abstract]   [Full Text] [Related]  

  • 28. Determination of corticosterone in rat plasma by competitive protein-binding assay and its use in assessing the effects of CB154 and perphenazine on adrenal function.
    Cameron EH; Scarisbrick JJ
    J Endocrinol; 1973 Jul; 58(1):27-8. PubMed ID: 4722533
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of prolactin secretion by ergot alkaloids.
    Nasr H; Pearson OH
    Acta Endocrinol (Copenh); 1975 Nov; 80(3):429-43. PubMed ID: 811032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolactin-suppressive effects of two aminotetralin analogs of dopamine: their use in the characterization of the pituitary dopamine receptor.
    Rick J; Szabo M; Payne P; Kovathana N; Cannon JG; Frohman LA
    Endocrinology; 1979 May; 104(5):1234-42. PubMed ID: 86438
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of lactation and prolactin secretion in rats by ergot alkaloids.
    Shaar CJ; Clemens JA
    Endocrinology; 1972 Jan; 90(1):285-8. PubMed ID: 5009064
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of the effects of four ergot derivatives on prolactin secretion by dispersed rat pituitary cells.
    Delitala G; Yeo T; Grossman A; Hathway NR; Besser GM
    J Endocrinol; 1980 Oct; 87(1):95-103. PubMed ID: 7430919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of thyrotropin and prolactin secretions in primary hypothyroidism by 2-Br-alpha-ergocryptine.
    Miyal K; Onishi T; Hosokawa M; Ishibashi K; Kumahara Y
    J Clin Endocrinol Metab; 1974 Aug; 39(2):391-4. PubMed ID: 4418165
    [No Abstract]   [Full Text] [Related]  

  • 34. Median eminence lesions and serum prolactin: influence of ovariectomy and ergocornine.
    Welsch CW; Squiers MD; Cassell E; Chen CL; Meites J
    Am J Physiol; 1971 Dec; 221(6):1714-7. PubMed ID: 4941908
    [No Abstract]   [Full Text] [Related]  

  • 35. Influence of nursing on the release of prolactin and GH in mice with high and low incidence of mammary tumors.
    Sinha YN; Salocks CB; Lewis UJ; VanderLaan WP
    Endocrinology; 1974 Oct; 95(4):947-54. PubMed ID: 4472149
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of ergovaline, loline, and dopamine antagonists on rat pituitary cell prolactin release in vitro.
    Strickland JR; Cross DL; Birrenkott GP; Grimes LW
    Am J Vet Res; 1994 May; 55(5):716-21. PubMed ID: 8067623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of pituitary tumor growth and function by ergot alkaloids.
    MacLeod RM; Lehmeyer JE
    Cancer Res; 1973 Apr; 33(4):849-55. PubMed ID: 4348776
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of ergocornine on perphenazine-and oestrogen-induced prolactin release.
    Kulkarni PN; Simpson AA
    J Endocrinol; 1974 Oct; 63(1):35-41. PubMed ID: 4418486
    [No Abstract]   [Full Text] [Related]  

  • 39. The pharmacologic blockade of the circhoral mode of LH secretion in the ovariectomized rhesus monkey.
    Bhattacharya AN; Dierschke DJ; Yamaji T; Knobil E
    Endocrinology; 1972 Mar; 90(3):778-86. PubMed ID: 4400337
    [No Abstract]   [Full Text] [Related]  

  • 40. Endocrine profile of a specific prolactin inhibitor: Br-ergocryptine (CB 154). A preliminary report.
    Del Pozo E; Friesen H; Burmeister P
    Schweiz Med Wochenschr; 1973 Jun; 103(23):847-8. PubMed ID: 4351250
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.